Literature DB >> 20819880

Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease.

Emad A Rakha1, Louise Adamson, Emily Bell, Keith Neal, Stephen D Ryder, Philip V Kaye, Guruprasad P Aithal.   

Abstract

BACKGROUND: Fatty liver disease (FLD), of either alcoholic (AFLD) or non-alcoholic (NAFLD) aetiologies, is characterised histologically by features that are lobulocentric that typically affect zone 3, in contrast with portal-based inflammation characteristics of other forms of chronic liver disease. AIM: The authors aimed to determine the prevalence and significance of portal inflammation in a cohort of adults diagnosed as having AFLD and NAFLD.
METHODS: From a histology database, the authors identified 160 patients with biopsy proven AFLD and 214 with NAFLD diagnosed between 1991 and 2001. All liver biopsies were reviewed by one pathologist to evaluate various histological features.
RESULTS: More than a mild degree of portal inflammation was found in 47% of AFLD compared with 30% in NAFLD subgroup. A higher degree of portal inflammation in AFLD was associated with a higher mean corpuscular volume, gamma glutamyl transferase (GGT) and alkaline phosphatase, and a lower platelet count and albumin, whereas in NAFLD this was associated with age, presence of diabetes, hypertension, body mass index (BMI), higher fasting blood glucose, cholesterol, alanine transaminase, GGT and ferritin. On regression analysis, portal inflammation was associated with the severity of steatosis (p=0.005), presence of ballooning (p=0.030) in NAFLD and severity of fibrosis in both AFLD and NAFLD (p<0.001).
CONCLUSIONS: Portal inflammation is a common component of histological spectrum of both AFLD and NAFLD. In both conditions portal inflammation is associated with clinical and histological features suggestive of advanced disease.

Entities:  

Mesh:

Year:  2010        PMID: 20819880     DOI: 10.1136/jcp.2010.079145

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Paul Angulo; David E Kleiner; Sanne Dam-Larsen; Leon A Adams; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Jill C Keach; Heather D Lafferty; Alisha Stahler; Svanhildur Haflidadottir; Flemming Bendtsen
Journal:  Gastroenterology       Date:  2015-04-29       Impact factor: 22.682

2.  Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

Authors:  Ju Dong Yang; Manal F Abdelmalek; Herbert Pang; Cynthia D Guy; Alastair D Smith; Anna Mae Diehl; Ayako Suzuki
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

3.  Does a combination of opisthorchiasis and ethyl alcohol consumption enhance early cholangiofibrosis, the risk of cholangiocarcinoma?

Authors:  Pranee Sriraj; Ratchadawan Aukkanimart; Thidarut Boonmars; Amornrat Juasook; Pakkayanee Sudsarn; Nadchanan Wonkchalee; Chawalit Pairojkul; Sakda Waraasawapati; Porntip Laummaunwai; Sirintip Boonjaraspinyo
Journal:  Parasitol Res       Date:  2013-06-27       Impact factor: 2.289

Review 4.  Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

5.  PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features.

Authors:  Eduardo Vilar-Gomez; Carlos J Pirola; Silvia Sookoian; Laura A Wilson; Tiebing Liang; Naga Chalasani
Journal:  Hepatology       Date:  2022-04-21       Impact factor: 17.298

Review 6.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

7.  Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score.

Authors:  Rish K Pai; Vipul Jairath; Malcolm Hogan; Guangyong Zou; Oyedele A Adeyi; Quentin M Anstee; Bashar A Aqel; Cynthia Behling; Elizabeth J Carey; Andrew D Clouston; Kathleen Corey; Brian G Feagan; David E Kleiner; Christopher Ma; Stefanie C McFarlane; Mazen Noureddin; Vlad Ratziu; Mark A Valasek; Zobair M Younossi; Stephen A Harrison; Rohit Loomba
Journal:  Hepatology       Date:  2022-04-06       Impact factor: 17.298

8.  Serum γ-glutamyltransferase level is associated with periodontal disease independent of drinking habits in Japanese adults.

Authors:  Toyoko Morita; Yoji Yamazaki; Chika Fujiharu; Takanori Ishii; Misae Seto; Norihide Nishinoue; Yoshiyuki Sasaki; Takayuki Kawato; Masafumi Motohashi; Masao Maeno
Journal:  Med Sci Monit       Date:  2014-10-31

Review 9.  Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin.

Authors:  Giuseppina Pisano; Rosa Lombardi; Anna Ludovica Fracanzani
Journal:  Int J Mol Sci       Date:  2016-05-05       Impact factor: 5.923

10.  Association between metabolic syndrome and liver histology among NAFLD patients without diabetes.

Authors:  Pushpjeet Kanwar; James E Nelson; Katherine Yates; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  BMJ Open Gastroenterol       Date:  2016-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.